In particular, a significant increase in serum MPO-DNA complexes (p < 0.0001) was observed in patients with type II diabetes who also have diabetic kidney disease when compared to control subjects (patients with type II diabetes without diabetic kidney disease). This evidence concerns the gene MPO and diabetic kidney disease.